2 months agoProgress, Potential, and Possibilities Weekly Re-Broadcast - 4/13/25ProgressPotentialAndPossibilities
2 months agoDr. Peter Ordentlich, Ph.D. - CSO & Founder, Syndax Pharmaceuticals - Reimagining Cancer TreatmentProgressPotentialAndPossibilities
